An observational study in Infertility, sponsored by Dina Mohamed Refaat Dakhly. Completed at 1 site in Egypt. Open to female participants aged 20 Years to 45 Years. Per ClinicalTrials.gov, last updated 2015-02-02.
Sponsored by Dina Mohamed Refaat Dakhly · Observational
While practicing the different assisted reproductive techniques, the investigators are faced daily by the problem of poor responder females, and the debate about predicting its results based on the outcome of the different ORTs used. Due to the cost of AMH as an indicator for ovarian response, the need to re-assess its role was essential in our community, which led us to conduct this prospective multi-center IVF study.
2,506 studies on the registry are indexed under Infertility; 407 are open to participants now.
This study's enrollment of 928 is above the median of 200 across 714 observational studies indexed under Infertility.
Browse Infertility studies →This is the only study on the registry with Dina Mohamed Refaat Dakhly as lead sponsor.
Counted across the registry records on this site, refreshed daily.
Poor responder females
Exclusion Criteria:
poor responder females with age less than 35
Other: transvaginal Ultrasound
poor responder females with age more than 35
Other: transvaginal Ultrasound
Number of MII oocytes
Time frame: 2 years
This study is completed, as verified in Jan 2015. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.